Hvidovre Hospital is a hospital in Hvidovre near Copenhagen in Denmark. It is administered by the Capital Region of Denmark. The hospital was built from 1968 to 1979 and was officially opened on March 26, 1976.

During the past decade, Hvidovre Hospital, Kardiologisk conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hvidovre Hospital, Kardiologisk" #1 collaborator was "Astellas Pharma US, Inc." with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Hvidovre Hospital, Kardiologisk" are "Atrial Fibrillation" (1 trials) and "Atrial Flutter" (1 trials). Many other conditions were trialed in "Hvidovre Hospital, Kardiologisk" in a lesser frequency.

Most popular intervention types in "Hvidovre Hospital, Kardiologisk" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Vernakalant Injection 20 mg/mL" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hvidovre Hospital, Kardiologisk" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Hvidovre Hospital, Kardiologisk". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Hvidovre Hospital, Kardiologisk, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hvidovre Hospital, Kardiologisk, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".